Status:
COMPLETED
PreAsthmaControl (PAC)
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Up to 6 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate the ability of budesonide, given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing...
Eligibility Criteria
Inclusion
- Children of asthmatic mothers form the COPSAC birth cohort study
Exclusion
- Children born more than 4 weeks preterm
- children with other systemic illness that atopy/allergy
- Children requiring mechanical ventilation at any time since birth.
Key Trial Info
Start Date :
November 1 1998
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00234390
Start Date
November 1 1998
End Date
December 1 2004
Last Update
January 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Copenhagen, Denmark